Post-CAR MCL DESCAR-T registry:
- 1-yr OS after brexu-cel failure 30%
- post-CAR outcomes better with RT (ORR 50%) and BsAb (ORR 43%)
- 1-yr OS 57% w/ BsAb
- most deaths due to MCL, some infections
2nd #ASH24 dataset showing better outcomes w/ BsAb in MCL post-CAR setting. #lymsm
- 1-yr OS after brexu-cel failure 30%
- post-CAR outcomes better with RT (ORR 50%) and BsAb (ORR 43%)
- 1-yr OS 57% w/ BsAb
- most deaths due to MCL, some infections
2nd #ASH24 dataset showing better outcomes w/ BsAb in MCL post-CAR setting. #lymsm
1 / 3
Comments